StreetInsider.com After-Hours Movers 04/19
StreetInsider.com After-Hours Movers:
Mentor Corporation (NYSE: MNT) 17% LOWER; expects Fiscal 2007 sales of $300 million to $302 million. The Company had previously guided that sales would be in the range of $305 million to $315 million. The consensus is $309.3 million. Mentor sees 2008 sales of $340 million to $355 million. The consensus is $371.9 million.
Robert Half (NYSE: RHI) 11% LOWER; reports Q1 EPS of $0.42, 4 cents worse than estimates.(0.46) Revenues were $1.1 billion vs. $1.10 billion consensus.
Stamps.com (Nasdaq: STMP) 8% LOWER; reports Q1 EPS of $0.14, in-line with estimates.(0.14) Revenues were $20.00 million vs. $21.59 million consensus. Sees FY EPS between $0.67-0.77 vs. consensus of $0.77.
Energy Conversion Devices, Inc. (ECD Ovonics) (Nasdaq: ENER) 7% LOWER; implementing an organizational restructuring plan to consolidate and realign its business activities and reduce annual costs by approximately $23 million. The company will incur restructuring and other related charges in the fourth quarter of the current fiscal year of $3 - 6 million, with additional charges in fiscal year 2008. Sees Q3 EPS of $27 million, which compares to the consensus of $32.6 million.
Nabi Biopharmaceuticals (Nasdaq: NABI) 6% HIGHER; executed a definitive agreement to sell its Aloprim for Injection product to Bioniche Teoranta. Bioniche Teoranta is based in Ireland and is part of Bioniche Pharma Group. The aggregate sale proceeds for Aloprim is $3.7 million.
Informatica (Nasdaq: INFA) 6% HIGHER; reports Q1 EPS of $0.15, 3 cents better than estimates.(0.12) Revenues were $87.1 million vs. $84.75 million consensus. Company approves $50 million stock buyback.
Capital One (NYSE: COF) 5.8% LOWER; reports Q1 EPS of $1.62, 37 cents worse than estimates.(1.99) Company revises FY EPS to between $7.00-7.40 vs. consensus of $7.71
Advanced Micro Devices (NYSE: AMD) 4% HIGHER; reports a Q1 loss of $0.90 (ex-items), 42 cents worse than estimates.(-.48) Revenues were $1.23 billion vs. $1.26 billion consensus. On the call, the company said they see some stabilization in pricing.
Oakley (NYSE: OO) 4% HIGHER; reports Q1 EPS of $0.08, 5 cents better than estimates.(0.03) Revenues were $199.2 million vs. $181.25 million consensus. Sees FY EPS of $0.95-0.98 vs. $0.96 consensus.
Intuitive Surgical (Nasdaq: ISRG) 3% HIGHER; reports Q1 EPS of $0.62, 9 cents better than estimates.(0.53) Revenues were $114.2 million vs. $110.74 million consensus.
Aeroflex Incorporated (Nasdaq: ARXX) 3% HIGHER; received from Veritas Capital a non-binding proposal, subject to due diligence and other conditions, for a leveraged recapitalization of Aeroflex in which Aeroflex's stockholders would receive a cash dividend of $14 per share and retain in the aggregate 21.2% of the fully diluted common equity in a significantly leveraged Aeroflex.
Mentor Corporation (NYSE: MNT) 17% LOWER; expects Fiscal 2007 sales of $300 million to $302 million. The Company had previously guided that sales would be in the range of $305 million to $315 million. The consensus is $309.3 million. Mentor sees 2008 sales of $340 million to $355 million. The consensus is $371.9 million.
Robert Half (NYSE: RHI) 11% LOWER; reports Q1 EPS of $0.42, 4 cents worse than estimates.(0.46) Revenues were $1.1 billion vs. $1.10 billion consensus.
Stamps.com (Nasdaq: STMP) 8% LOWER; reports Q1 EPS of $0.14, in-line with estimates.(0.14) Revenues were $20.00 million vs. $21.59 million consensus. Sees FY EPS between $0.67-0.77 vs. consensus of $0.77.
Energy Conversion Devices, Inc. (ECD Ovonics) (Nasdaq: ENER) 7% LOWER; implementing an organizational restructuring plan to consolidate and realign its business activities and reduce annual costs by approximately $23 million. The company will incur restructuring and other related charges in the fourth quarter of the current fiscal year of $3 - 6 million, with additional charges in fiscal year 2008. Sees Q3 EPS of $27 million, which compares to the consensus of $32.6 million.
Nabi Biopharmaceuticals (Nasdaq: NABI) 6% HIGHER; executed a definitive agreement to sell its Aloprim for Injection product to Bioniche Teoranta. Bioniche Teoranta is based in Ireland and is part of Bioniche Pharma Group. The aggregate sale proceeds for Aloprim is $3.7 million.
Informatica (Nasdaq: INFA) 6% HIGHER; reports Q1 EPS of $0.15, 3 cents better than estimates.(0.12) Revenues were $87.1 million vs. $84.75 million consensus. Company approves $50 million stock buyback.
Capital One (NYSE: COF) 5.8% LOWER; reports Q1 EPS of $1.62, 37 cents worse than estimates.(1.99) Company revises FY EPS to between $7.00-7.40 vs. consensus of $7.71
Advanced Micro Devices (NYSE: AMD) 4% HIGHER; reports a Q1 loss of $0.90 (ex-items), 42 cents worse than estimates.(-.48) Revenues were $1.23 billion vs. $1.26 billion consensus. On the call, the company said they see some stabilization in pricing.
Oakley (NYSE: OO) 4% HIGHER; reports Q1 EPS of $0.08, 5 cents better than estimates.(0.03) Revenues were $199.2 million vs. $181.25 million consensus. Sees FY EPS of $0.95-0.98 vs. $0.96 consensus.
Intuitive Surgical (Nasdaq: ISRG) 3% HIGHER; reports Q1 EPS of $0.62, 9 cents better than estimates.(0.53) Revenues were $114.2 million vs. $110.74 million consensus.
Aeroflex Incorporated (Nasdaq: ARXX) 3% HIGHER; received from Veritas Capital a non-binding proposal, subject to due diligence and other conditions, for a leveraged recapitalization of Aeroflex in which Aeroflex's stockholders would receive a cash dividend of $14 per share and retain in the aggregate 21.2% of the fully diluted common equity in a significantly leveraged Aeroflex.
You May Also Be Interested In
- Barclays reports U.S. hotel revenue per room up 8.2% in July
- Jefferies cuts US steel outlook as Canada tariff deal looms
- Marvell signs major custom silicon deal with Google, sell-side comments
Create E-mail Alert Related Categories
General News, Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share